Alexion Pharmaceuticals, Inc.
Get verified emails for Alexion Pharmaceuticals, Inc. employeesAbout Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc., founded in 1992 and headquartered in Boston, Massachusetts, develops medicines for rare diseases. A small team works on a broad challenge. The company focuses on addressing areas of significant unmet need and builds a diversified pipeline across multiple disease areas using a range of innovative modalities.
Alexion is known for translating complex complement system biology into novel medicines and continues to expand its global geographic footprint as part of AstraZeneca. That effort reaches rare disease patients around the world, and the company has offices in multiple locations.
Alexion employs between 1,001 and 5,000 people. Its work centers on rare disease research and the development of life-changing medicines for patients and communities affected by these conditions.
Need to reach the Alexion Pharmaceuticals, Inc. team directly? Find verified work emails for every employee with Snov.io
Insights
Updated 31 Aug 2026Alexion is positioning itself as a rare-disease leader. AstraZeneca describes the portfolio as “industry-leading” and says it is committed to improving care across rare diseases. The 2026 AAN Annual Meeting disclosure suggests the company is using scientific and medical congress activity to reinforce its clinical presence in the category.
The available source points to a strategy focused on advancing data and treatment impact in rare disease rather than broad-market expansion. That focus on meeting-level data and disease-specific care fits a specialist competitive posture against other rare-disease players. Short and pointed.
Investor and market signals in the supplied material are limited. Still, the public emphasis on portfolio strength and conference data reads as a sentiment-building move, with Alexion using external validation from a major medical meeting to support confidence in its franchise. The Alexion News Centre also points to ongoing company communications activity, which suggests a steady flow of updates for stakeholders.
Frequently asked questions
Alexion Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts, United States.
Alexion Pharmaceuticals, Inc. has 1001-5000 employees according to its company profile.
Alexion Pharmaceuticals, Inc. operates in the Biotechnology sector. Public valuation figures are not always disclosed for private companies.